Insight Molecular Diagnostics Inc. (IMDX) vs Vivani Medical, Inc. (VANI)
A side-by-side comparison of Insight Molecular Diagnostics Inc. and Vivani Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMDX
Insight Molecular Diagnostics Inc.
$3.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VANI
Vivani Medical, Inc.
$1.24HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IMDX vs VANI
growth of $100 · dividends reinvested · last 10yIMDX -96.9% (-29.4%/yr)VANI -98.4% (-34.0%/yr)IMDX compounded faster over this window
IMDX VANI
IMDX vs VANI: by the numbers
- •IMDX is the larger company ($109M vs $107M market cap).
- •Both run net losses; VANI's is the smaller (0.00% vs -2955.63% net margin).
Metrics side by side
Valuation
| Metric | IMDX | VANI |
|---|---|---|
| P/S ratio | 65.35 | N/A |
| P/B ratio | N/A | 5.64 |
Profitability
| Metric | IMDX | VANI |
|---|---|---|
| Gross margin | 11.17% | 0.00% |
| Operating margin | -754.08% | 0.00% |
| Net margin | -2955.63% | 0.00% |
| ROE | N/A | -138.73% |
| ROIC | -223.06% | -73.94% |
Growth (annualized)
| Metric | IMDX | VANI |
|---|---|---|
| Revenue CAGR (5Y) | 27.24% | N/A |
| Total return CAGR (5Y) | -44.39% | -32.72% |
Frequently asked
- How have IMDX and VANI total returns compared?
- Over the past 10 years, IMDX delivered -29.11% and VANI delivered -34.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Insight Molecular Diagnostics ROEVivani Medical ROEInsight Molecular Diagnostics operating marginVivani Medical operating marginInsight Molecular Diagnostics revenue growthVivani Medical revenue growthInsight Molecular Diagnostics free cash flowVivani Medical free cash flow
Insight Molecular Diagnostics & Vivani Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.